Search research articles
Contact Us
Filters
Showing results (211-220 of 289) with videos related to
Page
of 29
Sort By:
Cancer
|
June 26, 2026
Reply to "Real-world safety, prognostic, and design considerations in ketogenic diet trials for pancreatic cancer"
Diana L Hanna, Caroline G P Roberts, Gayle S Jameson, et al.
Life Sciences
|
January 1, 1997
Combat veterans with posttraumatic stress disorder exhibit decreased habituation of the P1 midlatency auditory evoked potential
G M Gillette, R D Skinner, L M Rasco, et al.
Transplantation Proceedings
|
October 26, 2010
Safety and effectiveness of ivabradine after cardiac transplantation
E Lage-Gallé, N Romero-Rodríguez, J Nevado-Portero, et al.
Cancer Chemotherapy and Pharmacology
|
November 25, 2014
Phase I study of the MEK inhibitor trametinib in combination with the AKT inhibitor afuresertib in patients with solid tumors and multiple myeloma
Anthony W Tolcher, Amita Patnaik, Kyriakos P Papadopoulos, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry
|
November 19, 2010
Chromium is not an essential trace element for mammals: effects of a "low-chromium" diet
Kristin R Di Bona, Sharifa Love, Nicholas R Rhodes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 14, 2020
Phase I Escalation and Expansion Study of Bemarituzumab (FPA144) in Patients With Advanced Solid Tumors and FGFR2b-Selected Gastroesophageal Adenocarcinoma
Daniel V T Catenacci, Drew Rasco, Jeeyun Lee, et al.
Food Microbiology
|
March 2, 2011
Using of infrared spectroscopy to study the survival and injury of Escherichia coli O157:H7, Campylobacter jejuni and Pseudomonas aeruginosa under cold stress in low nutrient media
Xiaonan Lu, Qian Liu, Di Wu, et al.
Cancer Chemotherapy and Pharmacology
|
June 22, 2018
A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer
Amita Patnaik, Michael Gordon, Frank Tsai, et al.
Cancer Chemotherapy and Pharmacology
|
July 10, 2016
Phase 1 study to evaluate the effect of the MEK inhibitor trametinib on cardiac repolarization in patients with solid tumours
Amita Patnaik, Anthony Tolcher, Kyriakos P Papadopoulos, et al.
Cancer Chemotherapy and Pharmacology
|
July 18, 2018
Correction to: A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer
Amita Patnaik, Michael Gordon, Frank Tsai, et al.
Page
of 29
Search research articles
Search
Showing results (211-220 of 289) with videos related to
Sort By:
Page
of 29
Cancer
|
June 26, 2026
Reply to "Real-world safety, prognostic, and design considerations in ketogenic diet trials for pancreatic cancer"
Diana L Hanna, Caroline G P Roberts, Gayle S Jameson, et al.
Life Sciences
|
January 1, 1997
Combat veterans with posttraumatic stress disorder exhibit decreased habituation of the P1 midlatency auditory evoked potential
G M Gillette, R D Skinner, L M Rasco, et al.
Transplantation Proceedings
|
October 26, 2010
Safety and effectiveness of ivabradine after cardiac transplantation
E Lage-Gallé, N Romero-Rodríguez, J Nevado-Portero, et al.
Cancer Chemotherapy and Pharmacology
|
November 25, 2014
Phase I study of the MEK inhibitor trametinib in combination with the AKT inhibitor afuresertib in patients with solid tumors and multiple myeloma
Anthony W Tolcher, Amita Patnaik, Kyriakos P Papadopoulos, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry
|
November 19, 2010
Chromium is not an essential trace element for mammals: effects of a "low-chromium" diet
Kristin R Di Bona, Sharifa Love, Nicholas R Rhodes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 14, 2020
Phase I Escalation and Expansion Study of Bemarituzumab (FPA144) in Patients With Advanced Solid Tumors and FGFR2b-Selected Gastroesophageal Adenocarcinoma
Daniel V T Catenacci, Drew Rasco, Jeeyun Lee, et al.
Food Microbiology
|
March 2, 2011
Using of infrared spectroscopy to study the survival and injury of Escherichia coli O157:H7, Campylobacter jejuni and Pseudomonas aeruginosa under cold stress in low nutrient media
Xiaonan Lu, Qian Liu, Di Wu, et al.
Cancer Chemotherapy and Pharmacology
|
June 22, 2018
A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer
Amita Patnaik, Michael Gordon, Frank Tsai, et al.
Cancer Chemotherapy and Pharmacology
|
July 10, 2016
Phase 1 study to evaluate the effect of the MEK inhibitor trametinib on cardiac repolarization in patients with solid tumours
Amita Patnaik, Anthony Tolcher, Kyriakos P Papadopoulos, et al.
Cancer Chemotherapy and Pharmacology
|
July 18, 2018
Correction to: A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer
Amita Patnaik, Michael Gordon, Frank Tsai, et al.
Page
of 29